Evidence map›Paper›PMID 31119154›Full record

ArticleBioMed research international2019

Microenvironment of

Ana Cristina Doria Dos Santos, Victor Hugo de Souza Marinho, Pedro Henrique de Aviz Silva, Barbarella de Matos Macchi, Mara Silvia Pinheiro Arruda, Edilene Oliveira da Silva, José Luiz Martins do Nascimento, Chubert Bernardo Castro de Sena

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Diosgenin ameliorates silica-induced tuberculosis in rats.Animal models and experimental medicine · 2025
    Article
  3. Expression of a uniqueFrontiers in microbiology · 2024
    Article
  4. Culture ofPathogens (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ana Cristina Doria Dos SantosLaboratory of Structural Biology, Institute of Biological Sciences, Federal University of Pará, Belém, PA, Brazil.
Victor Hugo de Souza MarinhoLaboratory of Structural Biology, Institute of Biological Sciences, Federal University of Pará, Belém, PA, Brazil.
Pedro Henrique de Aviz SilvaLaboratory of Structural Biology, Institute of Biological Sciences, Federal University of Pará, Belém, PA, Brazil.
Barbarella de Matos MacchiLaboratory of Molecular and Cellular Neurochemistry, Institute of Biological Sciences, Federal University of Pará, Belém, PA, Brazil.
Mara Silvia Pinheiro ArrudaLaboratory of Extraction, Institute of Natural Science, Federal University of Pará, Belém, PA, Brazil.
Edilene Oliveira da SilvaLaboratory of Structural Biology, Institute of Biological Sciences, Federal University of Pará, Belém, PA, Brazil.ORCID 0000-0001-6555-6868
José Luiz Martins do NascimentoLaboratory of Molecular and Cellular Neurochemistry, Institute of Biological Sciences, Federal University of Pará, Belém, PA, Brazil.ORCID 0000-0003-3475-4778
Chubert Bernardo Castro de SenaLaboratory of Structural Biology, Institute of Biological Sciences, Federal University of Pará, Belém, PA, Brazil.ORCID 0000-0002-2328-9885
Universidade Federal do Pará · BRNational Institute of Science and Technology for Structural Biology and Bioimaging · BRUniversidade Federal do Amapá · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogenic species of mycobacteria are known to use the host cholesterol during lung infection as an alternative source of carbon and energy. Mycobacteria culture in minimal medium (MM) has been used as an

Indexed as

Cell MembraneCellular MicroenvironmentCell WallCholesterolCulture MediaGranulomaHydrogen PeroxideLipopolysaccharidesMacrophagesMycobacterium smegmatisCholesterolCulture MediaHydrogen PeroxidelipoarabinomannanlipomannanLipopolysaccharides

Identifiers

PMID31119154
PMCPMC6500705
OpenAlexW2935945555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.